1. Results of Targeted Biopsy in Men with Magnetic Resonance Imaging Lesions Classified Equivocal, Likely or Highly Likely to Be Clinically Significant Prostate Cancer 
Wulphert Venderink, Annemarijke van Luijtelaar, Joyce G.R. Bomers, Marloes van der Leest, Christina Hulsbergen-van de Kaa, Jelle O. Barentsz, J.P. Michiel Sedelaar, Jurgen J. Fütterer 
European Urology 
DOI: /j.eururo
Copyright © 2017 European Association of Urology Terms and Conditions

2. Fig. 1
Patient flow chart. MRGB=magnetic resonance imaging guided prostate biopsy; PI-RADS=Prostate Imaging Reporting and Data System; PCa=prostate cancer; GS=Gleason score.
European Urology DOI: ( /j.eururo )
Copyright © 2017 European Association of Urology Terms and Conditions

3. Fig. 2
Detection rates differentiated per location. Clinically significant prostate cancer (csPCa) detection rates (%, n) are displayed based on the location of the lesion detected on multiparametric magnetic resonance imaging. For example, the csPCa detection rate for lesions covering both the mid and the apex region of the prostate is 57% (83/145). In Table 7, csPCa detection rates per subcohort are displayed.
European Urology DOI: ( /j.eururo )
Copyright © 2017 European Association of Urology Terms and Conditions